Bleeding Assessment in a Large Cohort of Patients with Osteogenesis Imperfecta

Overview

Journal Orphanet J Rare Dis

Publisher Biomed Central

Specialty General Medicine

Date 2024 Feb 12

PMID 38347577

Authors

Koert Gooijer

Gabriela Heidsieck

Arjan Harsevoort

Danielle Bout

Guus Janus

Anton Franken

Affiliations

Soon will be listed here.

Abstract

Background: Osteogenesis Imperfecta (OI) is characterised by bone fragility. Among several features, easy bruising and multiple case reports on haemorrhagic events have been reported. This paper describes the diverse manifestations of bleeding and bruising in a large cohort of 328 OI patients. The aim of this study is to provide insight in the diverse aspects and therapeutic considerations of bleedings in OI.

Methods: This descriptive cohort study was conducted at the National Expert Center for adults with OI in the Netherlands. Bleeding was assessed by the validated self-bleeding assessment tool (Self-BAT) The tool was distributed among 328 adults with different clinically confirmed types of OI.

Results: 195 of 328 invited patients (completion rate 60%) with OI type 1 (n = 144), OI type 3 (n = 17) and OI type 4 (n = 34), aged between 18 and 82 years, completed the tool. Self-BAT scores were above the normal range in 42% of all patients. For males Self-BAT scores were increased in 37% with a mean score of 3.7, ranged between 0 and 18. For females the Self-BAT scores were increased in 44% with a mean of 5.4 and a range of 0-24. No statistical differences in OI subtypes were found.

Conclusions: Bleeding tendency appears to be a relevant complication in OI patients as this study confirms the presumption of bleeding tendency. There are specific recommendations to clinicians who treat OI patients to consider an assessment of bleeding tendency and use potential interventions to reduce haemorrhagic complications and improve quality of life.

Citing Articles

Extra-Skeletal Manifestations in Osteogenesis Imperfecta Mouse Models.

Crawford T, Lafaver B, Phillips C Calcif Tissue Int. 2024; 115(6):847-862.

PMID: 38641703 DOI: 10.1007/s00223-024-01213-4.

References

Rydz N, James P . The evolution and value of bleeding assessment tools. J Thromb Haemost. 2012; 10(11):2223-9. PMC: 3893309. DOI: 10.1111/j.1538-7836.2012.04923.x. View

. Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. Lancet. 2017; 389(10084):2105-2116. PMC: 5446563. DOI: 10.1016/S0140-6736(17)30638-4. View

Paterson C, Monk E . Temporary brittle bone disease: association with intracranial bleeding. J Pediatr Endocrinol Metab. 2013; 26(5-6):417-26. DOI: 10.1515/jpem-2012-0272. View

Rodeghiero F, Castaman G, Tosetto A, Batlle J, Baudo F, Cappelletti A . The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: an international, multicenter study. J Thromb Haemost. 2005; 3(12):2619-26. DOI: 10.1111/j.1538-7836.2005.01663.x. View

Veen C, van der Reijken I, Jansen A, Schipaanboord C, Visser W, de Maat M . Severe postpartum haemorrhage as first presenting symptom of an inherited bleeding disorder. Haemophilia. 2019; 25(6):1051-1058. DOI: 10.1111/hae.13846. View

Waters D, Clark D, Symbas P, SCHLANT R . Aortic and mitral valve replacement in a patient with osteogenesis imperfecta. Chest. 1977; 72(3):363-4. DOI: 10.1378/chest.72.3.363. View

Boender J, Kruip M, Leebeek F . A diagnostic approach to mild bleeding disorders. J Thromb Haemost. 2016; 14(8):1507-16. DOI: 10.1111/jth.13368. View

Faqeih E, Roughley P, Glorieux F, Rauch F . Osteogenesis imperfecta type III with intracranial hemorrhage and brachydactyly associated with mutations in exon 49 of COL1A2. Am J Med Genet A. 2009; 149A(3):461-5. DOI: 10.1002/ajmg.a.32653. View

de Wee E, Knol H, Mauser-Bunschoten E, van der Bom J, Eikenboom J, Fijnvandraat K . Gynaecological and obstetric bleeding in moderate and severe von Willebrand disease. Thromb Haemost. 2011; 106(5):885-92. DOI: 10.1160/TH11-03-0180. View

10.

Chauleur C, Cochery-Nouvellon E, Mercier E, Aya G, Fabbro-Peray P, Mismetti P . Some hemostasis variables at the end of the population distributions are risk factors for severe postpartum hemorrhages. J Thromb Haemost. 2008; 6(12):2067-74. DOI: 10.1111/j.1538-7836.2008.03168.x. View

11.

Sadler J, Budde U, Eikenboom J, Favaloro E, Hill F, Holmberg L . Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor. J Thromb Haemost. 2006; 4(10):2103-14. DOI: 10.1111/j.1538-7836.2006.02146.x. View

12.

Oakley I, Reece L . Anesthetic implications for the patient with osteogenesis imperfecta. AANA J. 2010; 78(1):47-53. View

13.

van Dijk F, Sillence D . Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment. Am J Med Genet A. 2014; 164A(6):1470-81. PMC: 4314691. DOI: 10.1002/ajmg.a.36545. View

14.

Rodeghiero F, Tosetto A, Abshire T, Arnold D, Coller B, James P . ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. J Thromb Haemost. 2010; 8(9):2063-5. DOI: 10.1111/j.1538-7836.2010.03975.x. View

15.

Pereira J, Quiroga T, Mezzano D . Laboratory assessment of familial, nonthrombocytopenic mucocutaneous bleeding: a definitive diagnosis is often not possible. Semin Thromb Hemost. 2008; 34(7):654-62. DOI: 10.1055/s-0028-1104544. View

16.

Kastrup M, von Heymann C, Hotz H, Konertz W, Ziemer S, Kox W . Recombinant factor VIIa after aortic valve replacement in a patient with osteogenesis imperfecta. Ann Thorac Surg. 2002; 74(3):910-2. DOI: 10.1016/s0003-4975(02)03700-1. View

17.

Starr S, Roberts T, Fischer P . Osteogenesis imperfecta: primary care. Pediatr Rev. 2010; 31(8):e54-64. DOI: 10.1542/pir.31-8-e54. View

18.

Hathaway W, SOLOMONS C, Ott J . Platelet function and pyrophosphates in osteogenesis imperfecta. Blood. 1972; 39(4):500-9. View

19.

Malfait F, De Paepe A . Bleeding in the heritable connective tissue disorders: mechanisms, diagnosis and treatment. Blood Rev. 2009; 23(5):191-7. DOI: 10.1016/j.blre.2009.06.001. View

20.

Rothschild L, Goeller J, Voronov P, Barabanova A, Smith P . Anesthesia in children with osteogenesis imperfecta: Retrospective chart review of 83 patients and 205 anesthetics over 7 years. Paediatr Anaesth. 2018; 28(11):1050-1058. DOI: 10.1111/pan.13504. View